110
report
What Can Global North Learn from Global South: Lessons from Past Pandemics and Epidemics
Written by Jacobs and FasterCures, a center of the Milken Institute, this report highlights th
e de
+ Read More
report
Mapping the Journey: Building a Mutual Understanding for Health Equity in Clinical Research
If the objective of biomedical research is to spur innovation to create healthier communities, exte
nd life, and more effectively treat or cure disease, then persistent inequities run counter to that goal and create unnecessary barriers to health and wel
+ Read More
report
Community-Based Infrastructure for Inclusive Research: Engaging the Private Sector
Clinical trial networks, as evidenced during the COVID-19 pandemic, really are “national critical i
nfrastructure.” The pandemic revealed prominent gaps and stark differences in health outcomes across various populations.
+ Read More
report
Estimating Long-term Economic Returns of NIH Funding on Output in the Biosciences
Advances in biomedical research have spurred dramatic improvements in both human and economic healt
h.
+ Read More
report
Building Community-Based Infrastructure for Inclusive Research: Lessons from the Pandemic for Federal Action
COVID-19 has focused the public’s attention on the racial and ethnic disparities in health outcomes
, unequal access to health care, and some communities’ lack of trust and participation in medical research.
+ Read More
report
Data Governance for Early Warning Systems
The COVID-19 pandemic resulted in the proliferation of new data that have created unprecedented opp
ortunities to establish early warning systems for pandemics.
+ Read More
report
Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard
Since early in the COVID-19 pandemic, FasterCures has been committed to capturing lessons learned a
nd opportunities to improve the biomedical research ecosystem.
+ Read More
report
Employer Investments in Digital, Whole-Person Health for Substance Use Disorders
Employers seek to support their employees while normalizing a whole-person approach to substance us
e disorders (SUD). The response to addiction and the opioid crisis requires a whole-of-society approach, including employers of all sizes.
+ Read More
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
video
Technology Enabling Decentralized Trials, Novel Endpoints, Real World Data
New technologies and approaches to collection and use of patient data have the potential to revolu
tionize clinical research. How can patient organizations support this movement? What are potential pitfalls to watch out for?
+ Read More
video
Master Protocols, Adaptive Designs, and Bayesian Statistics – Oh My
Master Protocols, Adaptive Designs, and Bayesian Statistics: These innovative trial approaches are
sometimes described as being “patient-centric.” Are they? What are the challenges and opportunities for patient groups to support them?
+ Read More
video
Opportunities for Patient Group Engagement in Clinical Trials
What is the range of opportunities for patient foundations to support more rapid and effective cli
nical research, through preference studies and other patient insights, trial design and networks, recruitment and retention?
+ Read More